{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:14:34Z","timestamp":1791432874020,"version":"4.3.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ajo.2004.06.077","type":"journal-article","created":{"date-parts":[[2004,12,31]],"date-time":"2004-12-31T07:44:55Z","timestamp":1104479095000},"page":"925-930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab"],"prefix":"10.1016","volume":"138","author":[{"given":"James A.","family":"Garrity","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin W.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Eggenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Waitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2004.06.077_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0039-6257(84)90166-8","article-title":"The nonspecific orbital inflammatory syndromes","volume":"29","author":"Kennerdell","year":"1984","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0009-9260(05)80216-8","article-title":"Idiopathic inflammatory pseudotumour of the orbit","volume":"44","author":"McNicholas","year":"1991","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ajo.2004.06.077_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0039-6257(97)81996-0","article-title":"What is orbital pseudotumor?","volume":"41","author":"Mombaerts","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2214\/ajr.137.5.957","article-title":"Acute orbital pseudotumors","volume":"137","author":"Nugent","year":"1981","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ajo.2004.06.077_bib5","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0161-6420(94)31298-X","article-title":"Idiopathic sclerosing inflammation of the orbit","volume":"101","author":"Rootman","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2004.06.077_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/000348948909800702","article-title":"Sclerosing orbital pseudotumor","volume":"98","author":"Weissler","year":"1989","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.ajo.2004.06.077_bib7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0161-6420(96)30663-5","article-title":"Are systemic corticosteroids useful in the management of orbital pseudotumors?","volume":"103","author":"Mombaerts","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2004.06.077_bib8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0161-6420(97)30301-7","article-title":"Current status in the treatment of orbital myositis","volume":"104","author":"Mombaerts","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2004.06.077_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/030089169908500115","article-title":"Orbital pseudotumor","volume":"85","author":"Zurlo","year":"1999","journal-title":"Tumori"},{"key":"10.1016\/j.ajo.2004.06.077_bib10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1053-4296(99)80008-3","article-title":"Radiation therapy for benign disease of the orbit","volume":"9","author":"Smitt","year":"1999","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ajo.2004.06.077_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00002281-200205000-00002","article-title":"Tumor necrosis factor-\u03b1 antagonists for the treatment of rheumatic diseases","volume":"14","author":"Criscione","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ajo.2004.06.077_bib12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1572-0241.2001.03612.x","article-title":"Infliximab for Crohn\u2019s disease in clinical practice at the Mayo Clinic","volume":"96","author":"Ricart","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajo.2004.06.077_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00002281-200105000-00003","article-title":"Anti-tumor necrosis factor therapies","volume":"13","author":"Taylor","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ajo.2004.06.077_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0016-5085(99)70332-X","article-title":"Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn\u2019s disease","volume":"117","author":"Rutgeerts","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajo.2004.06.077_bib15","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra032906","article-title":"New drugs for rheumatoid arthritis","volume":"350","author":"Olsen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2004.06.077_bib16","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/archopht.1982.01030040729002","article-title":"Chronic orbital myositis","volume":"100","author":"Bullen","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib17","first-page":"41","article-title":"Acute recurrent orbital myositis","volume":"3","author":"Ludwig","year":"1983","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0161-6420(97)30300-5","article-title":"Outcome of orbital myositis","volume":"104","author":"Mannor","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2004.06.077_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9394(14)77789-X","article-title":"Acute and subacute orbital myositis","volume":"96","author":"Weinstein","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib20","first-page":"483","article-title":"Metastatic small cell carcinoma masquerading as orbital myositis","volume":"13","author":"Divine","year":"1982","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.ajo.2004.06.077_bib21","first-page":"245","article-title":"Indolent orbital apex syndrome caused by occult mucormycosis","volume":"12","author":"Dooley","year":"1992","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archopht.1994.01090150110032","article-title":"Orbital myositis as a paraneoplastic syndrome","volume":"112","author":"Harris","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib23","first-page":"257","article-title":"Orbital aspergillosis","volume":"17","author":"Hutnik","year":"1997","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib24","first-page":"103","article-title":"Aspergillosis presenting as a corticosteroid-responsive optic neuropathy","volume":"2","author":"Spoor","year":"1982","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0039-6257(01)00280-6","article-title":"Caught by a masquerade","volume":"47","author":"Thorne","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib26","first-page":"454","article-title":"High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy","volume":"29","author":"Tokayer","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajo.2004.06.077_bib27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/0003-4819-134-8-200104170-00013","article-title":"Rational use of new and existing disease-modifying agents in rheumatoid arthritis","volume":"134","author":"Kremer","year":"2001","journal-title":"Ann Intern Med"},{"issue":"Suppl 28","key":"10.1016\/j.ajo.2004.06.077_bib28","first-page":"S152","article-title":"Side effects of anti-TNF therapy","volume":"20","author":"Antoni","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ajo.2004.06.077_bib29","first-page":"985","article-title":"Retrobulbar optic neuritis associated with infliximab","volume":"120","author":"Foroozan","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib30","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1212\/WNL.57.10.1885","article-title":"Onset of multiple sclerosis associated with anti-TNF therapy","volume":"57","author":"Sicotte","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ajo.2004.06.077_bib31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bmj.326.7389.579","article-title":"Bilateral anterior toxic optic neuropathy and the use of infliximab","volume":"326","author":"ten Tusscher","year":"2003","journal-title":"BMJ"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2004.06.077_bib32","first-page":"1121","article-title":"The role of TNF\u03b1 and lymphotoxin in demyelinating disease","volume":"58","author":"Lock","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ajo.2004.06.077_bib33","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor \u03b1 therapy for inflammatory arthritides","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajo.2004.06.077_bib34","first-page":"1101","article-title":"Review article","volume":"15","author":"Aithal","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2004.06.077_bib35","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0016-5085(99)70294-5","article-title":"The relationship between infliximab treatment and lymphoma in Crohn\u2019s disease","volume":"117","author":"Bickston","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajo.2004.06.077_bib36","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293940400827X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293940400827X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:48:05Z","timestamp":1757594885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293940400827X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S000293940400827X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2004.06.077","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2004.06.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}